Skip to main content

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Publication ,  Journal Article
Villa, LL; Perez, G; Kjaer, SK; Paavonen, J; Lehtinen, M; Muñoz, N; Sigurdsson, K; Hernandez-Avila, M; Skjeldestad, FE; Thoresen, S; García, P ...
Published in: Obstetrical and Gynecological Survey
September 1, 2007

Duke Scholars

Published In

Obstetrical and Gynecological Survey

DOI

ISSN

0029-7828

Publication Date

September 1, 2007

Volume

62

Issue

9

Start / End Page

578 / 579

Related Subject Headings

  • Obstetrics & Reproductive Medicine
  • 4204 Midwifery
  • 3215 Reproductive medicine
  • 1114 Paediatrics and Reproductive Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Villa, L. L., Perez, G., Kjaer, S. K., Paavonen, J., Lehtinen, M., Muñoz, N., … Sviggum, O. (2007). Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. Obstetrical and Gynecological Survey, 62(9), 578–579. https://doi.org/10.1097/01.ogx.0000280190.01879.f9
Villa, L. L., G. Perez, S. K. Kjaer, J. Paavonen, M. Lehtinen, N. Muñoz, K. Sigurdsson, et al. “Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.” Obstetrical and Gynecological Survey 62, no. 9 (September 1, 2007): 578–79. https://doi.org/10.1097/01.ogx.0000280190.01879.f9.
Villa LL, Perez G, Kjaer SK, Paavonen J, Lehtinen M, Muñoz N, et al. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. Obstetrical and Gynecological Survey. 2007 Sep 1;62(9):578–9.
Villa, L. L., et al. “Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.” Obstetrical and Gynecological Survey, vol. 62, no. 9, Sept. 2007, pp. 578–79. Scopus, doi:10.1097/01.ogx.0000280190.01879.f9.
Villa LL, Perez G, Kjaer SK, Paavonen J, Lehtinen M, Muñoz N, Sigurdsson K, Hernandez-Avila M, Skjeldestad FE, Thoresen S, García P, Majewski S, Dillner J, Olsson SE, Tay EH, Xavier Bosch F, Ault KA, Brown DR, Ferris DG, Koutsky LA, Kurman RJ, Myers ER, Barr E, Boslego J, Bryan J, Esser MT, Gause CK, Hesley TM, Lupinacci LC, Sings HL, Taddeo FJ, Thornton AR, Boulos M, Cox JT, Langmark F, Modlin J, Muñoz A, Odlind V, Wilkinson E, Ferenczy A, Kurman R, Ronnett B, Stoler M, Andreoni G, Bahamondes L, Camargos A, Costa R, De Andrade R, Fedrizzi E, Ferriani R, Gonçalves M, Laginha F, Mendonça J, Moreira E, Nonnenmacher B, Taborda W, Zanetta D, Ardila J, Balcazar N, Maldonado I, Revollo F, Ruiz A, Andersen ES, Djursing H, Hansen T, Jørgensen JJ, Nilas L, Ottesen B, Petersen LK, Thomsen SG, Toftager-Larsen K, Apter D, Kekki M, Kuortti M, Lahti L, Lindroos Y, Lunnas T, Palmroth J, Lazcano E, Zertuche J, Dalaker K, Eriksen B, Ernø LE, Fiane B, Hesla K, Myhre Isachsen M, Iversen OE, Kasin K, Kristoffersen M, Lunde T, Nordmark PT, Nygaard T, Onsrud M, Riis-Johannessen G, Schiøtz H, Sundhagen H, Sviggum O. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. Obstetrical and Gynecological Survey. 2007 Sep 1;62(9):578–579.

Published In

Obstetrical and Gynecological Survey

DOI

ISSN

0029-7828

Publication Date

September 1, 2007

Volume

62

Issue

9

Start / End Page

578 / 579

Related Subject Headings

  • Obstetrics & Reproductive Medicine
  • 4204 Midwifery
  • 3215 Reproductive medicine
  • 1114 Paediatrics and Reproductive Medicine